Catalog

HSP90 Heat shock protein 90

Inhibitors

Cat.No.	Name	Information
M5997	Teprenone	Teprenone(Geranylgeranylacetone; GGA)is commonly utilized to protect the gastric mucosa in peptic ulcer disease; has been shown to protect the myocardium from ischemia/reperfusion by activating heat shock proteins.
M3884	Celastrol	Celastrol is a potent antioxidant and anti-inflammatory agent and a novel HSP90 inhibitor.
M3776	CH5138303	CH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM.
M3683	Retaspimycin	Retaspimycin is a novel, water-soluble, potent inhibitor of heat-shock protein 90 (Hsp90).
M3563	KW-2478	KW-2478 is a nonansamycin HSP90 inhibitor with IC50 of 3.8 nM.
M3561	Geldanamycin	Geldanamycin is a natural existing HSP90 inhibitor with K_d of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association.
M3528	SNX-2112	SNX-2112 selectively binds to the ATP pocket of HSP90α and HSP90β with K_a of 30 nM and 30 nM, uniformly more potent than 17-AAG.
M3432	SST0287CL1	SST0287CL1 is a potent Hsp90 inhibitor.
M3197	MPC-3100	MPC-3100 is a fully synthetic and potent Hsp90 inhibitor with IC50 of 60 nM.
M3117	VER-49009	VER-49009 is a potent HSP90 inhibitor with IC50 of 47 nM for HSP90β.
M2968	PU-H71	PU-H71 is a potent and selective inhibitor of HSP90 with IC50 of 51 nM.
M2885	NMS-E973	NMS-E973 is a potent and selective Hsp90 inhibitor with DC50 of <10 nM for Hsp90 binding, no activiy against a panel of 52 diverse protein kinases.
M2799	KU-32	KU-32 is a novel, novobiocin-based HSP90 inhibitor with EC50 of 240.2 nM.
M2777	IPI-504	IPI-504 (Retaspimycin) is a potent inhibitor of HSP90 with EC50 of 63 nM.
M2776	IPI-493	IPI-493 is a potent and orally bioavailable HSP90 inhibitor with K_i of 21 nM.
M2321	17-DMAG hydrochloride	17-DMAG (Alvespimycin, KOS-1022, NSC 707545) is a potent HSP90 inhibitor with IC50 of 62 nM.
M2320	17-AAG	17-AAG (Tanespimycin) is a potent HSP90 inhibitor with IC50of 5 nM.
M2083	Elesclomol	Elesclomol (formerly STA-4783) is a small-molecule investigational agent that selectively induces apoptosis in cancer cells by increasing oxidative stress.
M2070	XL888	XL888 is a novel small-molecule inhibitor of HSP90 with IC50 of 24 nM.
M2003	PF-04929113	PF-04929113 (SNX-5422) is a potent and selective Hsp90 inhibitor with Kd of 41 nM.
M1949	AT13387	AT13387 is a novel, high-affinity heat-shock protein 90 (HSP90) inhibitor with IC50 of 18 nM in A375 cells.
M1908	NVP-BEP800	NVP-BEP800 is a novel, fully synthetic, orally bioavailable inhibitor of Hsp90β with an IC50 of 58 nM.
M1798	NVP-HSP990	NVP-HSP990 is an orally bioavailable inhibitor of human heat-shock protein 90 (Hsp90) with potential antineoplastic activity.
M1762	AUY922	AUY922 (NVP-AUY922) is a small molecule Heat Shock Protein 90 (HSP90) inhibitor with IC50 values of 13 and 21 nM for HSP90α and HSP90β respectively.
M1741	Ganetespib	Ganetespib (STA-9090) is a potent synthetic small molecule inhibitor of Hsp90 with potential antineoplastic activity.
M1725	CUDC-305	CUDC-305 is a heat shock protein 90 (HSP90) inhibitor of the novel imidazopyridine class.
M1679	BIIB021	BIIB021 (CNF2024) is an orally available synthetic non-ansamycin Hsp90 inhibitor with ki value of 1.7nM.

HSP90 Heat shock protein 90

Get to Know Us

Customer Support

Resources

Contact Us